Project Overview
In 2021, the launch of a biosimilar medicine prompted our involvement in crafting a compelling value proposition tool. This tool aimed to empower Engagement Teams in instilling a pivotal realisation among prospects about the benefits of switching to the new biosimilar medicine.
We conceived and built a desktop application that delivers a visually immersive and persuasive value narrative to healthcare professionals (HCPs). Tailored to the specific Integrated Care System (ICS) being addressed by the Engagement Lead, the tool dynamically generates and showcases pertinent cost visualisations.
Our primary strategy was to illustrate the long-term financial impact of not embracing the new medication.
The Challenges
• Need to support the launch of a biosimilar medicine with a persuasive and differentiated value proposition.
• Difficulty in clearly communicating the long-term financial benefits of switching to the biosimilar to healthcare professionals.
• Engagement Teams lacked tools to deliver tailored, data-driven messaging to specific Integrated Care Systems (ICSs).
• Existing materials were insufficiently visual or compelling to prompt action from decision-makers.
• Urgency in demonstrating the cost of inaction to drive uptake of the new treatment.
Our Solution
In response to the 2021 launch of a biosimilar medicine, we developed a compelling value proposition tool to support Engagement Teams in communicating the benefits of switching to the new treatment.
We designed and built a desktop application that delivered a visually immersive and persuasive value narrative for healthcare professionals (HCPs). The tool was tailored to the specific Integrated Care System (ICS) being targeted, dynamically generating relevant cost visualisations.
Our core strategy focused on highlighting the long-term financial impact of not adopting the biosimilar, helping to drive informed decision-making and support uptake at the system level.